The National Healthcare Security Administration has recently stated that the “two-ticket policy” still plays an important role in drug procurement in medical institutions. Therefore, it should not be abolished at this time.
国家医保局：两票制暂不取消
来源：医药网 2022.10.25
日前，国家医保局明确，医疗机构药品采购“两票制”仍然发挥着重要作用，目前不适合取消。
Leave a Reply